← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2006Last known activity
Jul 31, 2025
Timeline
1940s
- Jun 1, 1946
Kissei Pharmaceuticals— Founded
Drugs by trial phase (26 distinct, 58 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Calculi
- Colitis
- Colitis, Ulcerative
- Constipation
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dry Eye Syndromes
- Endometriosis
- Hyperphosphatemia
- Hyperplasia
- Hyperuricemia
- Keratoconjunctivitis Sicca
- Kidney Diseases
- Mesothelioma
- Parkinson Disease
- Prostatic Hyperplasia
- Pruritus
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency, Chronic
- Sjogren's Syndrome
- Spinocerebellar Ataxias
- Spinocerebellar Degenerations
- Syndrome
- Ulcer
- Urinary Bladder, Overactive
- Urinary Calculi
Recent trials (50)
- NCT07040137Lead sponsorPhase 3Jul 31, 2025
- NCT07015268Lead sponsorPhase 3Jun 30, 2025
- NCT07015268OfficialPhase 3Jun 30, 2025
- NCT06722729OfficialPhase 2Dec 31, 2024
- NCT06722729Lead sponsorPhase 2Dec 31, 2024
- NCT06611696CollaboratorPhase 4Nov 15, 2024
- NCT05831670Study directorPhase 2Apr 27, 2023
- NCT05831670Lead sponsorPhase 2Apr 27, 2023
- NCT05440383Study directorPhase 3Oct 11, 2022
- NCT05445167Lead sponsorPhase 3Oct 11, 2022
- NCT05445167Study directorPhase 3Oct 11, 2022
- NCT05440383Lead sponsorPhase 3Oct 11, 2022
- NCT04867551Lead sponsorPhase 2May 15, 2021
- NCT04867551Study directorPhase 2May 15, 2021
- NCT04711603Lead sponsorPhase 3Jan 16, 2021
Details
- Founded
- Matsumoto, JP Jun 1, 1946
- Last known activity
- Jul 31, 2025